GPCR Structure Therapeutics Inc.
Executive Summary
A mixed institutional cluster in GPCR (2025-Q3) shows 4 buyers adding a net $6.0M against 3 sellers reducing by $51.6M. The sell-side dominates in dollar terms, led by Capital International's full exit and Citadel's deep trim. Buy-side additions are small-scale passive/quant rebalancing by State Street, UBS, RenTech, and DE Shaw. The cluster suggests risk-off institutional rotation out of mid-cap biotech positions, not a coordinated bullish thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$45.6M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| State Street | ADD | +37.5% | $1.3M | $595.0K |
| D.E. Shaw | DOUBLED | +198.8% | $1.0M | $765.0K |
| UBS | ADD | +36% | $5.8M | $2.7M |
| RenTech | ADD | +37.5% | $4.3M | $2.0M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Capital International Investor | EXIT | -100% | $33.6M | -$33.6M |
| Citadel | TRIM | -66.6% | $27.6M | -$15.1M |
| Morgan Stanley | TRIM | -37% | $19.0M | -$2.8M |
Actionable Insight
Large active manager exits (Capital International, Citadel) outweigh small passive additions, signaling diminished institutional conviction. Monitor next 13F for continuation — if quant firms also begin reducing, the rotation may accelerate. The 0% analyst-sell consensus (92% buy/strong-buy) contrasts sharply with the institutional footprint, creating a potential dislocation.
Key Facts
- Net institutional flow: +$6.0M buying vs -$51.6M selling — 89% of net dollar activity is selling
- Capital International exited completely, selling $33.6M (1.62M shares)
- Citadel trimmed 66.6% of its position worth $15.1M (from $27.6M to $12.4M)
- All 4 buyers added modestly: largest was UBS +$2.7M (passive), RenTech +$2.0M, DE Shaw +$765K, State Street +$595K
- Buyers are all passive/index/quant desks — no active fundamental fund additions
Financial Impact
3 institutions sold $51.6M in aggregate while 4 institutions added $6.0M — net institutional reduction of ~$45.5M
Risk Factors
- Passive/quant additions may reflect index rebalancing rather than fundamental conviction, masking continued active manager selling
- Capital International's full exit could indicate undisclosed thesis concerns (safety, efficacy, or data-timing issues on pipeline assets)
- Low historical win-rate on GPCR calls (0% T+20) suggests the stock is mean-reverting — the cluster signal may already be stale due to 45-day 13F lag
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-GPCR-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
Institutional Cluster
| $42.10 awaiting T+20 | awaiting T+20 | — | — |
|
May 7, 2026
5w ago
|
8-K
| $39.10 $37.58 | ▼ −3.89% | ▼ −3.91% | — |
|
Apr 27, 2026
6w ago
|
Press Release
| $43.56 $39.58 | ▼ −9.14% | ▼ −14.60% | — |
|
Apr 15, 2026
8w ago
|
8-K
| $54.25 $37.84 | ▼ −30.25% | ▼ −36.29% | — |
|
Mar 16, 2026
12w ago
|
Press Release
| $56.65 $53.22 | ▼ −6.05% | ▼ −9.83% | — |
|
Feb 28, 2026
15w ago
|
Institutional Cluster
| $62.90 $43.94 | ▼ −30.14% | ▼ −22.20% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access